MW 388.11 Da, Purity >98%. Bisphosphonate bone resorption inhibitor. Zoledronic acid (ab141980) derivative. Inhibits FFP synthase. Inhibits osteoclast activity. Potent angiogenesis inhibitor. Shows antitumor effects in vivo. .
MW 388.11 Da, Purity >98%. Bisphosphonate bone resorption inhibitor. Zoledronic acid (ab141980) derivative. Inhibits FFP synthase. Inhibits osteoclast activity. Potent angiogenesis inhibitor. Shows antitumor effects in vivo. .
Soluble in water.
Bisphosphonate bone resorption inhibitor. Zoledronic acid (ab141980) derivative. Inhibits FFP synthase. Inhibits osteoclast activity. Potent angiogenesis inhibitor. Shows antitumor effects in vivo.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
2D chemical structure image of ab143738, Zoledronate disodium salt, bisphosphonate bone resorption inhibitor
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com